Berjesh Sharda
Transplant Surgery · Indiana, PANPI 1962002576
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (55.8%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 83.3% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $3,029 and has fallen 87.4% since, to $383 in 2025.
Across 56 payments — averaging $108.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Johnson & Johnson$205
- Medtronic$124
- Sumitomo Pharma America, Inc.$111
- Axonics, Inc.$108
- Avanos Medical$94
- plus $374 from 13 others
What the payments were for
- Travel & lodging$3,39356%
- Food & beverage$1,18720%
- Education$1,50025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $5,064 |
| Johnson & Johnson(2 entities) | 7 | $205 |
| Medtronic | 3 | $124 |
| Sumitomo Pharma America, Inc. | 6 | $111 |
| Axonics, Inc. | 5 | $108 |
| Avanos Medical | 1 | $94 |
| Calyxo, Inc. | 3 | $57 |
| Procept Biorobotics Corporation | 2 | $55 |
| Cumberland Pharmaceuticals, Inc. | 2 | $36 |
| AbbVie | 1 | $34 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Laborie Medical Technologies Corp. | 1 | $31 |
| Boston Scientific | 2 | $28 |
| Coloplast | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Urogen Pharma, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,355
- DAVINCI XI$1,500
How this compares
$6,080 in reported general payments places this provider in the 85th percentile of 41 transplant surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 18 | $7,983 |
| Tolterodine Tartrate | 185 | $7,174 |
| Tolterodine Tartrate ErTolterodine Tartrate | 45 | $3,259 |
| Tamsulosin Hcl | 222 | $3,042 |
| Estradiol | 27 | $1,732 |
| Dutasteride | 56 | $1,488 |
| Silodosin | 33 | $1,465 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $562 |
| Duloxetine Hcl | 43 | $513 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 29 | $452 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 20 | $410 |
| Oxybutynin Chloride | 13 | $337 |
| Bicalutamide | 11 | $198 |
| Levofloxacin | 60 | $161 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Indiana
- Michael MarvinDanville$143K
- Adam BodzinPhiladelphia$75K
- Peter AbtPhiladelphia$10K
- Anil KotruDanville$8K
- Ira FoxPittsburgh$7K
- Muhammad SaeedPhiladelphia$4K
- Kenneth AndreoniPhiladelphia$4K
- Armando Ganoza SalasPittsburgh$3K
- Ignazio MarinoPhiladelphia$3K
- Christine duAllentown$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.